We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FORA:NASDAQForian Inc. Analysis

Data as of 2026-06-17 - not real-time

$2.17

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Forian Inc. is trading in a narrow range between its identified support and resistance levels, with price perched just below the upper barrier. The short‑term SMA sits marginally above the mid‑term SMA, suggesting a slight bullish bias, yet the MACD histogram is negative and the signal line is flagged as bearish, indicating downward momentum pressure. Momentum remains modestly elevated as reflected by an RSI that is approaching the upper third of its scale, hinting at limited upside before a potential pullback. Fundamentally, the company shows a stark contrast between a healthy cash position and negative profitability metrics, while the forward earnings outlook turns positive, and the discounted cash flow model places fair value well above the current market price, presenting a valuation gap. The sector—health information services—carries moderate regulatory exposure and the stock’s beta is exceptionally low, implying limited market‑wide volatility, though the small market cap and thin trading volume raise liquidity considerations. Overall, the technical setup suggests caution in the very short run, but the valuation disparity and improving earnings outlook provide a catalyst for medium‑ to long‑term investors.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • price near resistance with bearish MACD signal
  • RSI approaching overbought territory
  • limited short‑term upside given current momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value substantially above market price
  • forward earnings turning positive
  • low beta indicating defensive profile in a volatile market

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • persistent cash cushion offsetting earnings volatility
  • sector growth potential in health data analytics
  • ongoing liquidity constraints limiting rapid price appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth-2.90%
Profit Margin-17.00%
P/E Ratio24.1
ROE-17.95%
ROA-8.37%
Debt/Equity0.02
P/B Ratio2.3
Op. Cash Flow$1.9M
Free Cash Flow$4.2M
Industry P/E24.3

Technical Analysis

TrendNeutral
RSI64.0
Support$2.15
Resistance$2.18
MA 20$2.16
MA 50$2.12
MA 200$2.13
MACDBearish
VolumeStable
Fear & Greed Index88.5

Valuation

Fair Value$2.77
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.15
Volatility8.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.